We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Natco, Alvogen Reportedly Settle with Gilead Over Tamiflu Copy
Natco, Alvogen Reportedly Settle with Gilead Over Tamiflu Copy
India’s Natco Pharma and partner Alvogen announced Monday that they have settled a patent infringement suit filed by Gilead Sciences, Roche and Genentech over a proposed generic version of Tamiflu.